Literature DB >> 24233603

Characterization of human immunodeficiency virus-1 (HIV-1) rev by (time-resolved) fluorescence spectroscopy.

A J Kungl1, C Seidel, A Schilk, T J Daly, H F Kauffmann, M Auer.   

Abstract

Fluorescence spectroscopy has been applied to the single tryptophan-containing regulatory protein Rev of human immunodeficiency virus (HIV-1). The fluorescence emission was found to have a maximum at 336 nm which refers to a surrounding of the chromophore of intermediate polarity. Fluorescence transients recorded at the maximum of fluorescence were found to decay nonexponentially. A bimodal lifetime distribution is obtained from exponential series analysis (ESM) with centers at 1.7 and 4.5 ns. Two microenvironments for tryptophan are suggested to be responsible for the two lifetime distributions. No innerfilter effect occurred in a Rev solution up to a concentration of 40 μM. A data quality study of ESM analysis as function of collected counts in the peak channel maximum (CIM) showed that, for reliable reconvolution, at least 15,000 CIM are necessary. The widths of the two distributions are shown to be temperature dependent. The broadening of the lifetime distributions when the temperature is raised to 50°C is interpreted as extension of the number of conformational substates which do not interconvert on the fluorescence time scale. The thermal deactivation (temperature quenching) is reflected in a constant decrease in the center of the short-lived lifetime distribution.

Entities:  

Year:  1994        PMID: 24233603     DOI: 10.1007/BF01881444

Source DB:  PubMed          Journal:  J Fluoresc        ISSN: 1053-0509            Impact factor:   2.217


  25 in total

Review 1.  Fluorescence techniques for studying protein structure.

Authors:  M R Eftink
Journal:  Methods Biochem Anal       Date:  1991

2.  HIV-1 Rev expressed in recombinant Escherichia coli: purification, polymerization, and conformational properties.

Authors:  P T Wingfield; S J Stahl; M A Payton; S Venkatesan; M Misra; A C Steven
Journal:  Biochemistry       Date:  1991-07-30       Impact factor: 3.162

3.  Sequence-specific RNA binding by the HIV-1 Rev protein.

Authors:  M L Zapp; M R Green
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

4.  HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.

Authors:  M H Malim; L S Tiley; D F McCarn; J R Rusche; J Hauber; B R Cullen
Journal:  Cell       Date:  1990-02-23       Impact factor: 41.582

5.  Perturbation of the carboxy terminus of HIV-1 Rev affects multimerization on the Rev responsive element.

Authors:  T J Daly; P Rennert; P Lynch; J K Barry; M Dundas; J R Rusche; R C Doten; M Auer; G K Farrington
Journal:  Biochemistry       Date:  1993-08-31       Impact factor: 3.162

6.  Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif.

Authors:  T J Hope; X J Huang; D McDonald; T G Parslow
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

7.  Conformational substates and motions in myoglobin. External influences on structure and dynamics.

Authors:  M K Hong; D Braunstein; B R Cowen; H Frauenfelder; I E Iben; J R Mourant; P Ormos; R Scholl; A Schulte; P J Steinbach
Journal:  Biophys J       Date:  1990-08       Impact factor: 4.033

8.  Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells.

Authors:  B Mermer; B K Felber; M Campbell; G N Pavlakis
Journal:  Nucleic Acids Res       Date:  1990-04-25       Impact factor: 16.971

9.  Definition of the human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex protein activation domain by functional exchange.

Authors:  I Weichselbraun; G K Farrington; J R Rusche; E Böhnlein; J Hauber
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Functional analysis of CAR, the target sequence for the Rev protein of HIV-1.

Authors:  E T Dayton; D M Powell; A I Dayton
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.